Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
AGIOS PHARMACEUTICALS, INC. has filed 1,294 SEC EDGAR filings since 01 Jul 2008

SEC filing history

Showing 826-850 of 1,000 matching filings.

Per page
25
Current page
34
4

FORM 4 SUBMISSION

Filing date
15 Sep 2017
Reporting date
13 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Sep 2017
Reporting date
11 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Sep 2017
Reporting date
11 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Sep 2017
Reporting date
01 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Sep 2017
Reporting date
01 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
24 Aug 2017
Reporting date
22 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
21 Aug 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
11 Aug 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36014

FORM 8-K

Filing date
08 Aug 2017
Reporting date
08 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
07 Aug 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Aug 2017
Reporting date
01 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Aug 2017
Reporting date
01 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Jul 2017
Reporting date
19 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 Jul 2017
Reporting date
07 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Jul 2017
Reporting date
03 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
27 Jun 2017
Reporting date
23 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36014

FORM 8-K

Filing date
26 Jun 2017
Reporting date
24 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Jun 2017
Reporting date
21 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Jun 2017
Reporting date
13 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Jun 2017
Reporting date
13 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Jun 2017
Reporting date
13 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Jun 2017
Reporting date
13 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Jun 2017
Reporting date
13 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .